Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1966 3
1967 10
1968 2
1969 6
1970 3
1971 1
1972 2
1973 1
1974 3
1991 1
1993 1
1996 1
1998 2
1999 1
2000 3
2002 1
2003 2
2006 1
2011 4
2012 2
2013 1
2014 4
2015 1
2017 4
2018 6
2019 2
2020 4
2021 3
2022 4
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Pignata S, Scambia G, Katsaros D, Gallo C, Pujade-Lauraine E, De Placido S, Bologna A, Weber B, Raspagliesi F, Panici PB, Cormio G, Sorio R, Cavazzini MG, Ferrandina G, Breda E, Murgia V, Sacco C, Cinieri S, Salutari V, Ricci C, Pisano C, Greggi S, Lauria R, Lorusso D, Marchetti C, Selvaggi L, Signoriello S, Piccirillo MC, Di Maio M, Perrone F; Multicentre Italian Trials in Ovarian cancer (MITO-7); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens et du sein (GINECO); Mario Negri Gynecologic Oncology (MaNGO); European Network of Gynaecological Oncological Trial Groups (ENGOT-OV-10); Gynecologic Cancer InterGroup (GCIG) Investigators. Pignata S, et al. Among authors: bologna a. Lancet Oncol. 2014 Apr;15(4):396-405. doi: 10.1016/S1470-2045(14)70049-X. Epub 2014 Feb 28. Lancet Oncol. 2014. PMID: 24582486 Clinical Trial.
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial.
Pignata S, Lorusso D, Joly F, Gallo C, Colombo N, Sessa C, Bamias A, Salutari V, Selle F, Frezzini S, De Giorgi U, Pautier P, Bologna A, Orditura M, Dubot C, Gadducci A, Mammoliti S, Ray-Coquard I, Zafarana E, Breda E, Favier L, Ardizzoia A, Cinieri S, Largillier R, Sambataro D, Guardiola E, Lauria R, Pisano C, Raspagliesi F, Scambia G, Daniele G, Perrone F; MITO16b/MANGO–OV2/ENGOT–ov17 Investigators. Pignata S, et al. Among authors: bologna a. Lancet Oncol. 2021 Feb;22(2):267-276. doi: 10.1016/S1470-2045(20)30637-9. Lancet Oncol. 2021. PMID: 33539744 Clinical Trial.
Oligonucleotide-Peptide Complexes: Phase Control by Hybridization.
Vieregg JR, Lueckheide M, Marciel AB, Leon L, Bologna AJ, Rivera JR, Tirrell MV. Vieregg JR, et al. Among authors: bologna aj. J Am Chem Soc. 2018 Feb 7;140(5):1632-1638. doi: 10.1021/jacs.7b03567. Epub 2018 Jan 26. J Am Chem Soc. 2018. PMID: 29314832
Chronobiology of acute pancreatitis in a single Italian centre.
Guarino M, Bologna A, Ursini F, De Giorgi A, Alfano F, Gambuti E, Marchesini M, Strada A, Volpato S, De Giorgio R. Guarino M, et al. Among authors: bologna a. Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):1988-1994. doi: 10.26355/eurrev_202002_20376. Eur Rev Med Pharmacol Sci. 2020. PMID: 32141567 Free article.
[Antivitamins].
BOLOGNA A. BOLOGNA A. Med Ital. 1947-1948;27(6):284-9. Med Ital. 1947. PMID: 18906823 French. No abstract available.
[Hepatic cell transplantation in childhood. State of the art].
Bologna AA, Barbich MR, D'Agostino D, Argibay PF. Bologna AA, et al. Arch Argent Pediatr. 2011 Apr;109(2):142-9. doi: 10.1590/S0325-00752011000200009. Arch Argent Pediatr. 2011. PMID: 21465073 Free article. Review. Spanish.
[Clinical applications of MIBG SPECT in chronic heart failure].
Savarese G, Losco T, Parente A, Musella F, Pirozzi E, Mosca S, Casaretti L, Formisano R, Conte S, Bologna A, Mattiello G, Perrone-Filardi P. Savarese G, et al. Among authors: bologna a. G Ital Cardiol (Rome). 2012 Feb;13(2):91-7. doi: 10.1714/1021.11141. G Ital Cardiol (Rome). 2012. PMID: 22322548 Review. Italian.
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer.
Vergote I, du Bois A, Floquet A, Rau J, Kim JW, Del Campo JM, Friedlander M, Pignata S, Fujiwara K, Colombo N, Mirza MR, Monk BJ, Tsibulak I, Calvert PM, Herzog TJ, Hanker LC, Meunier J, Lee JY, Bologna A, Carrasco-Alfonso MJ, Harter P. Vergote I, et al. Among authors: bologna a. Gynecol Oncol. 2019 Nov;155(2):186-191. doi: 10.1016/j.ygyno.2019.08.024. Epub 2019 Sep 10. Gynecol Oncol. 2019. PMID: 31519320 Free article. Clinical Trial.
84 results